Chicago, Oct. 14, 2022 (GLOBE NEWSWIRE) — Veterinary Pain Management Market is expected to grow from $1.8 billion in 2022 to $2.5 billion by 2027, at a CAGR of 6.7% from 2022 to 2027, according to a new report by MarketsandMarkets™. Pain is the physiological term used to describe the chemical processes at work in the body that receive a stimulus, modify it, and transmit it to the brain for interpretation and response. The stimulus can be physical, temperature, chemical, or inflammatory tissue damage. In veterinary practices, pain is treated with analgesic drugs and devices.
Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96167677
Browse the detailed table of contents on “Veterinary Pain Management Market“
299—Tables
56 – Numbers
298 pages
In this report, the Veterinary Pain Management market has been segmented on the basis of product, application, animal type, end user and region.
“NSAIDs are expected to be the fastest growing market by drug type during the forecast period.”
The veterinary pain management market is segmented on the basis of drug type into NSAIDs, opioids, local anaesthetics, alpha-2 agonists, osteoarthritis disease modifying drugs and other drugs. In 2021, the NSAIDs segment accounted for the largest share of the veterinary pain reliever market. The large share of this segment is due to the widespread adoption of NSAIDs in a wide range of indications due to the low cost of these drugs.
“The oral segment is expected to register the fastest growth over the forecast period.”
The pain management veterinary drugs market is segmented into oral, parenteral and topical segments on the basis of route of administration. The oral segment accounted for the largest share of the veterinary pain reliever market by route of administration in 2021. The oral administration segment had the largest share, as orally administered drugs are convenient, easy to store, …
